Compound ID | 3316
Synonym(s): ABAC40411 | ABAC 40411
Class: Small molecule antibacterial agent
Spectrum of activity: | Gram-positive |
Details of activity: | Active against Streptococcus pneumoniae; intended indication for community acquired pneumonia (CAP) and other upper respiratory infections (URTI) |
Institute where first reported: | ABAC Therapeutics |
Year first mentioned: | 2024 |
Highest developmental phase: | Preclinical |
Development status: | Active |
External links: | |
Citations: |
|